Abstract
This presentation was given at the American Academy of Neurology Annual Meeting.
| Original language | American English |
|---|---|
| State | Published - 2004 |
| Event | American Academy of Neurology Annual Meeting (AAN) - Duration: Apr 23 2018 → … |
Conference
| Conference | American Academy of Neurology Annual Meeting (AAN) |
|---|---|
| Period | 04/23/18 → … |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Disciplines
- Public Health
- Epidemiology
Keywords
- Dyskinesia
- Keppra
- Levetiracetam
- Levodopa-induced
- Parkinson's disease
- Treatment
Fingerprint
Dive into the research topics of 'Levetiracetam (Keppra) in the Treatment of Levodopa-Induced Dyskinesia in Parkinson’s Disease'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver